Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
08/02/2001 | CA2395671A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2395666A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2395654A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2395403A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2395398A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2395295A1 Nucleic acids, proteins and antibodies |
08/02/2001 | CA2395178A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2394841A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2394039A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2393954A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2393941A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2393912A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2393652A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2393618A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2393002A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2392757A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2392751A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2392438A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2392428A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2392422A1 Nucleic acids, proteins, and antibodies |
08/02/2001 | CA2392398A1 Nucleic acids, proteins, and antibodies |
08/01/2001 | EP1120465A1 D-Aminoacylase and gene encoding the same |
08/01/2001 | EP1120461A1 Process for producing copolymerized polyester |
08/01/2001 | EP1119631A2 Transgene assay using stable agrobacterium rhizogenes transformation |
08/01/2001 | EP1119629A2 Oxidoreductase molecules |
08/01/2001 | EP1119628A2 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |
08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
08/01/2001 | EP1119621A2 G-protein coupled receptor proteins |
08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
08/01/2001 | EP1119617A2 Fusions of scaffold proteins with random peptide libraries |
08/01/2001 | EP1119616A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
08/01/2001 | EP1119615A1 PRODUCTION OF ssDNA IN VIVO |
08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
08/01/2001 | EP1119582A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
08/01/2001 | EP1119369A1 Vascular endothelial growth factor 3 |
08/01/2001 | EP1119345A1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
08/01/2001 | EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
08/01/2001 | EP0777489B1 Low molecular yeast active substance extract and process for preparing the same |
08/01/2001 | EP0698106B1 Marker gene |
08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
08/01/2001 | EP0643135B1 Dna encoding aspartokinase iii mutants and their use for the production of l-threonine by fermentation |
08/01/2001 | EP0498827B1 Improved plasmid vectors for cellular slime moulds of the genus dictyostelium |
08/01/2001 | EP0463024B1 Dna construct and modified yeast |
08/01/2001 | CN1306580A Mumbaistatin, process for its prodn. and its use as pharmaceutical |
08/01/2001 | CN1306577A Multiply-substituted protease variants |
08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
08/01/2001 | CN1306542A Moraxella catharralis proteins |
08/01/2001 | CN1306437A Vaccine |
08/01/2001 | CN1306425A Process for synthesizing Cox-2 inhibitors |
08/01/2001 | CN1306400A Drinks and foods capable of eliminating helicobacter pylori |
08/01/2001 | CN1306088A Process for culturing SOD lactobacillus |
08/01/2001 | CN1306084A Artificially cultured schizophyllum sporophores and its culture process |
08/01/2001 | CN1306007A Dry cell factor |
08/01/2001 | CN1305694A Antifoulant for rapid fermentation of raw edible fungus material |
08/01/2001 | CA2330023A1 Levodione reductase gene and use thereof |
07/31/2001 | US6269312 Apparatus and method for automated protein design |
07/31/2001 | US6268549 DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
07/31/2001 | US6268482 Recombinant cytokine designated LERK-6 |
07/31/2001 | US6268478 From new world primate and having specific vitamin d binding activity of at least 17,588-fold greater than endogenous protein; therapy and diagnosis of osteoporosis and hypercalcemia; drug screening |
07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
07/31/2001 | US6268471 Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof |
07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
07/31/2001 | US6268334 Cells include cardiovascular cells, and the peptide may be delivered in a stent to treat or prevent restinosis. |
07/31/2001 | US6268328 Variant EGIII-like cellulase compositions |
07/31/2001 | US6268206 Comprising mixture of at least one compound selected from camp, cgmp, forskolin, adenylate cyclase, guanylate cyclase, a derivative of camp, a derivative of cgmp, a derivative of forskolin, a derivative of adenylate cyclase |
07/31/2001 | US6268203 A isolated and pure culture isolated from cultivated plant material of the genus lythrum; a mycoherbicide |
07/31/2001 | US6268198 A recombinant dna molecule encoding an orpinomyces cellulase protein; for the conversion of cellulose to glucose for carbon sources for fuel and chemical production |
07/31/2001 | US6268196 Contacting fabric containing cellulose with a treating agent consisting of a truncated cellulase lacking a cellulase binding domain, incubating fabric with cellulase; improving the feel of fabric and giving the fabric a stonewash look |
07/31/2001 | US6268195 A genetically engineered plant pectin methyl esterase enyzme; used in the food industry as a thickening or gelling agent, such as in the preparation of jams. |
07/31/2001 | US6268193 A non-glycosylated protein; therapeutic agent in organ transplant rejection; therapeutic agent blocking attachment of bacterial, viral, or parasitic pathogens glycoconjugate receptors; contraceptive uses |
07/31/2001 | US6268188 Transaminases and aminotransferases |
07/31/2001 | US6268185 Production of amino acids and enzymes used therefor |
07/31/2001 | US6268180 A nucleic acid encoding a polypeptide; production of biologically active interleukin |
07/31/2001 | US6268178 Phage-dependent super-production of biologically active protein and peptides |
07/31/2001 | US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics |
07/31/2001 | US6268175 A polynucleotide; therapy for respiratory tract infections; development of antibiotics |
07/31/2001 | US6268171 Recombinant PilC proteins, methods for producing them and their use |
07/31/2001 | US6268169 Nucleic acids sequences encoding synthetic dragline variant protein; production of fabrics that are both light-weight and flexible without compromising strength and durability |
07/31/2001 | US6268154 Method for detecting bacterial nitrite oxidizer |
07/31/2001 | US6268140 Combinatorial metabolic libraries |
07/31/2001 | US6268134 Method and applications for efficient genetic suppressor elements |
07/31/2001 | US6267979 Providiny aqueous system formulation comprising chelating agent, an antimicrobial to control growth of microorganisms |
07/31/2001 | US6267966 Vaccine production of the Bacillus anthracis protective antigen |
07/31/2001 | US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor |
07/31/2001 | US6267888 Biodispersion as a method for removal of hydrocarbon oil from marine aqueous environments |
07/31/2001 | CA2218372C Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
07/31/2001 | CA2079877C Bacillus thuringiensis strains and their genes encoding insecticidal toxins |
07/31/2001 | CA2069428C A mammalian cytokine, il-11 |
07/26/2001 | WO2001053530A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
07/26/2001 | WO2001053525A2 Cell isolation method |
07/26/2001 | WO2001053512A1 Solventless extraction process |
07/26/2001 | WO2001053490A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
07/26/2001 | WO2001053487A2 Human sperm specific lysozyme-like proteins |
07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
07/26/2001 | WO2001053474A2 Flavobacterium heparinum expression system |
07/26/2001 | WO2001053469A2 Phosphatases |
07/26/2001 | WO2001053468A2 Lipid metabolism enzymes and polynucleotides encoding them |
07/26/2001 | WO2001053459A1 Process for producing l-lysine |